BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6093942)

  • 1. Hyperthermic response of the cat to intraventricular injection of the opioid delta-receptor agonist D-Ala2-D-Leu5-enkephalin.
    Pang IH; Bernardini GL; Clark WG
    Brain Res Bull; 1984 Aug; 13(2):263-8. PubMed ID: 6093942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).
    Ukai M; Holtzman SG
    Psychopharmacology (Berl); 1988; 94(1):32-7. PubMed ID: 2894701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermoregulatory effects of (D-ala2)-methionine-enkephalinamide in the cat. Evidence for multiple naloxone-sensitive opioid receptors.
    Clark WG; Ponder SW
    Brain Res Bull; 1980; 5(4):415-20. PubMed ID: 6250678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
    Porreca F; Burks TF
    J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intrahypothalamic injection of [D-Ala2,D-Leu5]enkephalin on feeding and temperature in the rat.
    Tepperman FS; Hirst M
    Eur J Pharmacol; 1983 Dec; 96(3-4):243-9. PubMed ID: 6373308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICI 154,129, a delta-opioid receptor antagonist raises seizure threshold in rats.
    Tortella FC; Robles LE; Holaday JW; Cowan A
    Eur J Pharmacol; 1984 Jan; 97(1-2):141-4. PubMed ID: 6321207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extreme hyperthermia induced in cats by the enkephalin analog FK 33-824.
    Clark WG; Bernardini GL; Ponder SW
    Pharmacol Biochem Behav; 1982 Jun; 16(6):989-93. PubMed ID: 6287503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D-Ala2,Leu5,Cys6]enkephalin: short-term agonist effects and long-term antagonism at delta opioid receptors.
    Calcagnetti DJ; Fanselow MS; Helmstetter FJ; Bowen WD
    Peptides; 1989; 10(2):319-26. PubMed ID: 2547203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-dimensional analysis of behavior in mice treated with the delta opioid agonists DADL (D-Ala2-D-Leu5-enkephalin) and DPLPE (D-Pen2-L-Pen5-enkephalin).
    Ukai M; Toyoshi T; Kameyama T
    Neuropharmacology; 1989 Oct; 28(10):1033-9. PubMed ID: 2554179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of opioid peptides and morphine applied intrathecally and intracerebroventricularly on the micturition reflex in the cat.
    Hisamitsu T; de Groat WC
    Brain Res; 1984 Apr; 298(1):51-65. PubMed ID: 6586255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.